Konsensuspapier Therapie der akuten Reisediarrhö

[1]  B. Jessica,et al.  Travellers' diarrhoea , 2017 .

[2]  D. Freedman,et al.  Medical Considerations before International Travel. , 2016, The New England journal of medicine.

[3]  S. Suerbaum,et al.  S2k-Leitlinie Gastrointestinale Infektionen und Morbus Whipple , 2015, Zeitschrift für Gastroenterologie.

[4]  N. Ajami,et al.  Characterization of the human gut microbiome during travelers' diarrhea , 2015, Gut microbes.

[5]  J. Ollgren,et al.  Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  S. Guandalini.  Probiotics for Prevention and Treatment of Diarrhea , 2011, Journal of clinical gastroenterology.

[7]  Mathias W Pletz,et al.  Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany. , 2015, International journal of medical microbiology : IJMM.

[8]  F. Verdam,et al.  Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic Steatohepatitis , 2011, Journal of clinical gastroenterology.

[9]  S. Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.

[10]  P. Collignon,et al.  Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[11]  O. Cars,et al.  Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers , 2010, Antimicrobial Agents and Chemotherapy.

[12]  I. Odenholt,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea , 2010, Scandinavian journal of infectious diseases.

[13]  G. De Sarro,et al.  Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes , 2010, European Journal of Clinical Pharmacology.

[14]  H. Dupont,et al.  Expert review of the evidence base for self-therapy of travelers' diarrhea. , 2009, Journal of travel medicine.

[15]  H. Dupont,et al.  Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. , 2007, Journal of travel medicine.

[16]  M. Thabane,et al.  Systematic review and meta‐analysis: the incidence and prognosis of post‐infectious irritable bowel syndrome , 2007, Alimentary pharmacology & therapeutics.

[17]  T. Fukui,et al.  Probiotics in the prevention of traveler's diarrhea: meta-analysis. , 2007, Journal of clinical gastroenterology.

[18]  L. Mcfarland.  Meta-analysis of probiotics for the prevention of traveler's diarrhea. , 2007, Travel medicine and infectious disease.

[19]  R. Steffen.  Epidemiology of traveler's diarrhea. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  N. Beeching,et al.  Traveller's diarrhoea. , 2005, The Lancet. Infectious diseases.

[21]  M. Shieh,et al.  A blind, randomized comparison of racecadotril and loperamide for stopping acute diarrhea in adults. , 2005, World journal of gastroenterology.

[22]  D. Prado.  A Multinational Comparison of Racecadotril and Loperamide in the Treatment of Acute Watery Diarrhoea in Adults , 2002 .

[23]  D. Turck,et al.  Comparison of racecadotril and loperamide in children with acute diarrhoea , 1999, Alimentary pharmacology & therapeutics.

[24]  J. Lecomte,et al.  Racecadotril versus placebo in the treatment of acute diarrhoea in adults , 1999, Alimentary pharmacology & therapeutics.

[25]  T. Ishizaki,et al.  Review article: cytochrome P450 and the metabolism of proton pump inhibitors — emphasis on rabeprazole , 1999, Alimentary pharmacology & therapeutics.

[26]  J. Schwartz,et al.  The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide. , 1993, Scandinavian journal of gastroenterology.

[27]  J. Schwartz,et al.  Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea. , 1992, Gut.

[28]  K. Alestig,et al.  Symptomatic treatment of acute infectious diarrhoea: loperamide versus placebo in a double-blind trial. , 1986, The Journal of infection.

[29]  R. Steffen.  Epidemiology of travelers diarrhea. , 1969 .